首页 | 本学科首页   官方微博 | 高级检索  
     

多发性骨髓瘤患者外周血与骨髓中瘤细胞的检测及临床意义
引用本文:蒋元强,李建勇,吴雨洁,杨慧,沈云峰,陈丽娟,徐卫,钱思轩,吴汉新,陆化,盛瑞兰. 多发性骨髓瘤患者外周血与骨髓中瘤细胞的检测及临床意义[J]. 中国实验血液学杂志, 2006, 14(5): 908-912
作者姓名:蒋元强  李建勇  吴雨洁  杨慧  沈云峰  陈丽娟  徐卫  钱思轩  吴汉新  陆化  盛瑞兰
作者单位:1. 南京医科大学第一附属医院血液科,南京,210029
2. 南京医科大学附属无锡第一医院血液科,无锡,210002
基金项目:江苏省卫生厅"135工程"医学重点人才基金
摘    要:本研究探讨多发性骨髓瘤(MM)患者的循环骨髓瘤细胞(circulating myeloma cells,CMC)和骨髓骨髓瘤细胞(marrow myeloma cells,MMC)的相关性及其临床意义。采用四色流式细胞术对55例MM患者同时检测CMC和MMC的百分率,并结合患者的β2微球蛋白(β2-MG)、血浆白蛋白(Alb)水平、染色体核型、肾功能等预后相关指标进行系统分析。将患者分成4组:A组为同时检测到CMC和MMC患者;B组为仅检测到MMC患者;C组为仅检测到CMC患者;D组为未检测到瘤细胞患者。结果发现:与其他各组相比,A组的β2-MG和肌酐浓度显著增高,白蛋白水平明显低下。就上述预后因素而言,在检测到与未检测到骨髓瘤细胞患者之间,差异有统计学意义。初发、复发/难治患者的CMC和MMC百分率明显高于部分缓解和完全缓解的患者。骨髓瘤患者CMC与MMC显著相关。结论:骨髓瘤患者CMC和MMC百分率不仅反映肿瘤负荷,而且预示病情进展,特别是同时检测到CMC和MMC的多发性骨髓瘤患者。

关 键 词:多发性骨髓瘤  骨髓瘤细胞  循环骨髓瘤细胞  骨髓骨髓瘤细胞
文章编号:1009-2137(2006)05-0908-05
收稿时间:2005-04-10
修稿时间:2006-07-31

Detection of Circulating and Bone Marrow Myeloma Cells in Patients with Multiple Myeloma and Its Clinical Significance
JIANG Yuan-Qiang,LI Jian-Yong,WU Yu-Jie,YANG Hui,SHEN Yun-Feng,CHEN Li-Juan,XU Wei,QIAN Si-Xuan,WU Han-Xin,LU Hua,SHEN Rui-Lan. Detection of Circulating and Bone Marrow Myeloma Cells in Patients with Multiple Myeloma and Its Clinical Significance[J]. Journal of experimental hematology, 2006, 14(5): 908-912
Authors:JIANG Yuan-Qiang  LI Jian-Yong  WU Yu-Jie  YANG Hui  SHEN Yun-Feng  CHEN Li-Juan  XU Wei  QIAN Si-Xuan  WU Han-Xin  LU Hua  SHEN Rui-Lan
Affiliation:Department of Hematology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
Abstract:This study was aimed to investigate the correlation between circulating myeloma cells (CMC) and bone marrow myeloma cells (MMC) in patients with multiple myeloma (MM) and its clinical significance. Four-color flow cytometry was used to detect the percentage of CMC and MMC in 55 patients with MM. Other prognosis-associated factors such as beta(2) microglobulin (beta(2)-MG), serum albumin (Alb), chromosomal abnormalities and renal function were simultaneously analyzed. The patients were divided into four groups: group A, in which CMC and MMC were simultaneously detected; group B, in which only MMC were detected; group C, in which only CMC were detected; group D, in which no myeloma cells were detected in peripheral blood or bone marrow. The results showed that the concentrations of beta(2)-MG and creatinine were significantly increased and Alb markedly decreased in group A as compared with other groups. Statistical differences existed in the above-mentioned factors between patients with myeloma cells detected and not detected. The percentages of CMC or MMC in newly diagnosed, refractory and relapsed patients were apparently higher than those in patients with partial and complete remission, respectively. CMC were strikingly correlated with MMC. It is concluded that the percentages of CMC and MMC not only imply tumor load in MM patients, but also predict the progression of MM, respectively for patients with MM, in those patients CMC and MMC were simultaneously detected.
Keywords:multiple myeloma   myeloma cell   circulating myeloma cell   bone marrw myeloma cell
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号